Editorial: Lipid metabolism dysregulation in obesity-related diseases and neurodegeneration
Frontiers in Endocrinology,
Год журнала:
2025,
Номер
16
Опубликована: Фев. 11, 2025
Editorial:
Lipid
Metabolism
Dysregulation
in
Obesity-Related
Diseases
and
Neurodegeneration
Provisionally
accepted
Язык: Английский
Top-Down Proteomic Profiling of Protein Corona by High-Throughput Capillary Isoelectric Focusing-Mass Spectrometry
Reyhane Tabatabaeian Nimavard,
Seyed Amirhossein Sadeghi,
Morteza Mahmoudi
и другие.
Journal of the American Society for Mass Spectrometry,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 2, 2025
In
the
rapidly
evolving
field
of
nanomedicine,
understanding
interactions
between
nanoparticles
(NPs)
and
biological
systems
is
crucial.
A
pivotal
aspect
these
formation
a
protein
corona
when
NPs
are
exposed
to
fluids
(e.g.,
human
plasma),
which
significantly
influences
their
behavior
functionality.
This
study
introduces
an
advanced
capillary
isoelectric
focusing
tandem
mass
spectrometry
(cIEF-MS/MS)
platform
designed
enable
high-throughput
reproducible
top-down
proteomic
analysis
corona.
Our
cIEF-MS/MS
technique
completed
each
within
30
min.
It
produced
proteoform
measurements
for
at
least
50
runs
regarding
proteoforms'
migration
time
[relative
standard
deviations
(RSDs)
<4%],
intensity
(Pearson's
correlation
coefficients
any
two
>0.90),
number
identifications
(71
±
10),
proteoform-spectrum
matches
(PrSMs)
(196
30).
Of
53
identified
genes,
33
potential
biomarkers
various
diseases
cancer,
cardiovascular
disease,
Alzheimer's
disease).
We
1-102
proteoforms
per
biomarker,
containing
sequence
variations
or
post-translational
modifications.
Delineating
in
by
our
fashion
will
benefit
nanobiointeractions
advance
both
diagnostic
therapeutic
nanomedicine
technologies.
Язык: Английский
Proteome of Renal Tubuli and Serum Differentiate Pre‐Existing Type 2 Diabetes and Post‐Transplant Diabetes in Kidney Transplant Recipients
PROTEOMICS - CLINICAL APPLICATIONS,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 24, 2025
Diabetes
mellitus
(DM)
is
a
major
cause
of
end-stage
kidney
disease
(ESKD),
with
transplantation
being
the
preferred
treatment.
However,
post-transplant
diabetes
(PTDM)
increases
mortality
and
graft
loss.
While
PTDM
Type
2
(T2DM)
share
risk
factors,
their
mechanisms
differ,
particularly
in
diabetic
nephropathy
(DN).
This
study
aimed
to
investigate
molecular
differences
by
mapping
proteomes
proximal
tubuli
serum
normoglycemic
(NG),
pre-transplant
T2DM,
patients
one
year
post-transplantation.
Experimental
Design
Proteomic
analysis
was
performed
on
microdissected
tubular
cells
samples
from
transplant
recipients
categorized
as
NG,
or
at
Mass
spectrometry
used
identify
differentially
expressed
proteins.
Data
analyses
were
using
gene
ontology
databases
pathway
analysis.
revealed
key
differences,
including
significant
dysregulation
mitochondrial
proteins
lipid
metabolism
pathways
compared
T2DM
NG
groups.
Additionally,
we
observed
distinct
patterns
cholesterol
PTDM,
highlighting
complex
interplay
between
fatty
acid
metabolism,
dysfunction
systemic
that
may
drive
renal
injury
PTDM-related
DN.
pilot
first
perform
proteomic
both
recipients.
The
could
help
develop
targeted
therapies
early
diagnostic
markers,
ultimately
improving
outcomes
patient
management.
Further
research
needed
validate
these
findings
explore
therapeutic
potential.
Язык: Английский
Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases
Diabetologia,
Год журнала:
2024,
Номер
67(12), С. 2626 - 2636
Опубликована: Авг. 24, 2024
Язык: Английский
Innovative Drug Discovery: Targeting Cancer, Neurological Disorders, and Obesity
ACS Medicinal Chemistry Letters,
Год журнала:
2024,
Номер
15(9), С. 1440 - 1442
Опубликована: Авг. 21, 2024
The
landscape
of
therapeutic
innovation
is
rapidly
evolving,
with
significant
advances
in
cancer
treatment,
obesity
management,
and
the
modulation
protein
interactions
neurodegenerative
disorders.
This
Patent
Highlight
explores
scientific
breakthroughs
described
four
recent
patents
covering
novel
compounds,
advanced
methods
for
identifying
E3
ligase
substrates,
developing
new
strategies
combating
its
related
metabolic
These
innovations,
focusing
on
specific
molecular
targets
pathways,
promise
more
effective
personalized
treatment
options,
addressing
unmet
needs
oncology,
neurology,
health.
Язык: Английский
Circulating Proteomic Profiles in Women with Morbid Obesity Compared to Normal-Weight Women
Research Square (Research Square),
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 30, 2024
Abstract
In
this
study,
we
aimed
to
evaluate
circulating
proteomic
levels
in
women
with
morbid
obesity
(MO)
compared
normal-weight
(NW)
women.
Moreover,
have
the
profile
between
metabolically
healthy
(MH)
MO
and
those
type
2
diabetes
mellitus
(T2DM).
The
study
included
66
129
(54
MH
75
T2DM).
Blood
samples
were
processed
for
proteomics,
involving
protein
extraction,
quantification,
digestion
peptide
labelling
NanoLC-(Orbitrap)MS/MS
analysis.
Statistical
analyses
performed.
We
identified
257
proteins.
Women
showed
significantly
increased
of
35
proteins
decreased
45
NW
Enrichment
analysis
metabolic
pathways
revealed
significant
findings.
an
altered
women,
related
chylomicron
assembly,
complement
cascade,
clotting
insulin
growth
factor
system.
Regarding
T2DM
MHMO
shows
alterations
mostly
same
associated
obesity.
These
findings
confirmed
previous
reports
can
help
us
better
understand
pathophysiology
diseases.
Язык: Английский
Personalized phosphoproteomics of skeletal muscle insulin resistance and exercise links MINDY1 to insulin action
Cell Metabolism,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 1, 2024
Type
2
diabetes
is
preceded
by
a
defective
insulin
response,
yet
our
knowledge
of
the
precise
mechanisms
incomplete.
Here,
we
investigate
how
resistance
alters
skeletal
muscle
signaling
and
exercise
partially
counteracts
this
effect.
We
measured
parallel
phenotypes
phosphoproteomes
insulin-resistant
(IR)
insulin-sensitive
(IS)
men
as
they
responded
to
(n
=
19,
114
biopsies),
quantifying
over
12,000
phosphopeptides
in
each
biopsy.
Insulin
involves
selective
time-dependent
alterations
signaling,
including
reduced
insulin-stimulated
mTORC1
non-canonical
responses.
Prior
promotes
sensitivity
even
IR
individuals
"priming"
portion
prior
infusion.
This
includes
MINDY1
S441,
which
show
an
AKT
substrate.
found
that
knockdown
enhances
glucose
uptake
rat
myotubes.
work
delineates
identifies
regulator
action.
Язык: Английский